StevensDA, KanVL, JudsonMA, MorrisonVA, DummerS, DenningDW, et al. Practice guidelines for diseases caused by Aspergillus; Infectious Diseases Society of America. Clin Infect Dis, 2000; 30(4):696–709.
2.
De PauwB, WalshTJ, DonnellyJP, StevensDA, EdwardsJE, CalandraT, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis, 2008; 46(12):1813–1821.
3.
MeerssemanW, VandecasteeleSJ, WilmerA, VerbekenE, PeetermansWE, Van WijngaerdenE. Invasive aspergillosis in critically ill patients without malignancy. Am J Respir Crit Care Med, 2004; 170(6):621–625.
4.
TrofRJ, BeishuizenA, Debets-OssenkoppYJ, GirbesARJ, GroeneveldABJ. Management of invasive pulmonary aspergillosis in non-neutropenic critically ill patients. Intensive Care Med, 2007; 33(10):1694–1703.
MaertensJ, MaertensV, TheunissenK, MeerssemanW, MeerssemanP, MeersS, et al. Bronchoalveolar lavage fluid galactomannan for the diagnosis of invasive pulmonary aspergillosis in patients with hematologic diseases. Clin Infect Dis, 2009; 49(11):1688–1693.
11.
KlontRR, Mennink-KerstenMA, VerweijPE. Utility of Aspergillus antigen detection in specimens other than serum specimens. Clin Infect Dis, 2004; 39(10):1467–1474.
12.
Mennink-KerstenMA, DonnellyJP, VerweijPE. Detection of circulating galactomannan for the diagnosis and management of invasive aspergillosis. Lancet Infect Dis, 2004; 4(6):349–357.
13.
VandewoudeKH, BlotSI, DepuydtP, BenoitD, TemmermanW, ColardynF, VogelaersD. Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care, 2006; 10(1):R31.
14.
TarrandJJ, LichterfeldM, WarraichI, LunaM, HanXY, MayGS, KontoyiannisDP. Diagnosis of invasive septate mold infections: a correlation of microbiological culture and histologic or cytologic examination. Am J Clin Pathol, 2003; 119(6):854–858.
